Evaluation of the Canadian Clinical Practice Guidelines Risk Prediction Tool for Acute Aortic Syndrome: The RIPP...

Area of Science:

• Cardiology
• Emergency Medicine
• Clinical Decision Support

Background:

• Acute aortic syndrome (AAS) is a critical condition with high mortality.
• Misdiagnosis of AAS is a significant concern in clinical practice.
• Clinical decision aids aim to improve diagnostic accuracy and patient outcomes.

Purpose of the Study:

• To validate the diagnostic accuracy of the RIPP score, a clinical decision aid for AAS.
• To compare the performance of the RIPP score against other existing risk prediction tools for AAS.
• To assess the utility of the RIPP score in facilitating clinician decision-making for AAS.

Main Methods:

• A historical case-control study was conducted involving consecutive cases and controls from three academic emergency departments (2002-2020).
• Cases were identified by AAS diagnosis, while controls presented with relevant symptoms like chest pain or perfusion deficits.
• Diagnostic accuracy was evaluated using C statistics, sensitivity, and specificity, with comparisons made using the DeLong method.

Main Results:

• The RIPP score exhibited a high sensitivity of 99.7% but a lower specificity (53%) compared to other tools.
• The RIPP score demonstrated a higher C statistic than the ADDRS and AORTAs scores.
• No significant difference was found between the RIPP score and the Lovy tool, while it was lower than the Von Kodolitsch tool.

Conclusions:

• The Canadian clinical practice guideline's AAS decision aid (RIPP score) is a highly sensitive diagnostic tool.
• It utilizes readily available clinical information, enhancing its practical application.
• The RIPP score holds potential for improving the diagnosis of AAS in emergency department settings.